PHR (Phreesia, Inc.) Stock Analysis - SEC Filings

Phreesia, Inc. (PHR) is a publicly traded Healthcare sector company. As of May 21, 2026, PHR trades at $8.85 with a market cap of $560.91M and a P/E ratio of 219.88. PHR moved -3.65% today. Year to date, PHR is -48.31%; over the trailing twelve months it is -65.28%. Its 52-week range spans $7.77 to $32.76. Analyst consensus is buy with an average price target of $14.43. Rallies surfaces PHR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find PHR SEC filings?

Rallies organizes PHR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

PHR Key Metrics

Key financial metrics for PHR
MetricValue
Price$8.85
Market Cap$560.91M
P/E Ratio219.88
EPS$0.04
Dividend Yield0.00%
52-Week High$32.76
52-Week Low$7.77
Volume0
Avg Volume0
Revenue (TTM)$480.59M
Net Income$2.31M
Gross Margin0.00%

Latest PHR News

Recent PHR Insider Trades

  • Hoffman Allison C sold 6.18K (~$55.95K) on Apr 20, 2026.
  • Hui Yvonne sold 1.33K (~$12.31K) on Apr 17, 2026.
  • Hui Yvonne sold 10.06K (~$91.37K) on Apr 16, 2026.

PHR Analyst Consensus

16 analysts cover PHR: 0 strong buy, 10 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $14.43.

Common questions about PHR

Where can I find PHR SEC filings?
Rallies organizes PHR SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show PHR 10-K and 10-Q filings?
Rallies organizes PHR SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is PHR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for PHR. It does not provide personalized investment advice.
PHR

PHR